NS5B: Difference between revisions

(12 intermediate revisions by 3 users not shown)

Line 1:

==RNA Dependent RNA Polymerase from Hepatitis C Virus==

NS5B is the RNA dependent RNA polymerase of Hepatitis C virus. NS5B, like other RNA dependent RNA polymerases, is error prone. This viral RNA replicase is of approximately a million times lower fidelity than a replicative prokayrotic or eukaryotic DNA polymerase. This is due in part to the fact that NS5B contains no exonuclease or proofreading domain. IN NS5B two divalent cations coordinated by carboxyl groups (as seen in DNA polymerases) catalyze the polymerization of monomers of RNA triphosphates to extend a primer strand, that may have initiated ''de novo''. In the case of NS5B the residues that coordinate divalent cations (Mg2+ or Mn2+ ''in vitro'') are the three <scene name='NS5B/Native_ns5b/7'>active site aspartates (220, 318 and 319)</scene> seen here (PDB entry [[2hai]]).

Though Hepatitis C virus is of the Flaviviridae family the structure of NS5B is similar to the polymerase of bacteriophage Φ 6. The similarity to the bacteriophage polymerase is due to NS5B containing a fully encircled active site. Like many template-dependent nucleotide polymerases, NS5B can be visualized similar to a right hand. NS5B contains several <scene name='NS5B/Native_ns5b/8'>domains</scene>, fingers in blue, palm in magenta, thumb in green and a c-terminal domain in yellow. The palm ~~domain contains~~ the ~~active site aspartates~~ and ~~there~~ are ~~several contacts between~~ the fingers and ~~thumbs~~ domain that ~~give~~ the active site ~~an encircled structure~~. ~~There~~ is a

In 2019, there were approximately 290,000 deaths due to a Hepatitis C infection. The majority of these deaths were largely due to the long-term adverse effects such as cirrhosis and liver cancer. Currently in the world, about 58 million people are chronically infected with the Hepatitis C virus and there are about 1.5 million new infections annually. In the United States, data estimates that 2.4 million people are infected with Hepatitis C. Due to the low percentage of diagnoses and the frequency of acute infection, it is believed that the number of Hepatitis C infections can range anywhere from 2.5 million to 4.7 million infected individuals. Nearly all of RNA viruses depend on specific activities performed by RNA dependent RNA polymerases (RdRp). These activities importantly include the copying of the RNA sequence and facilitating the process of transcription. Therefore, if a vaccine was created to target the RNA dependent RNA polymerase and inhibit the function of this protein, then the viral genome could not be replicated. If replication halts, the infection cannot spread to other cells. Due to the viral dependence on RdRps, it is essential to understand the structure for further antiviral drug research. [[Sofosbuvir]] is an inhibitor of NS5B used for Hepatitis C treatment.

<scene name='NS5B/Native_ns5b/9'>beta-hairpin in thumb domain</scene> that is proposed to move upon formation of exiting double stranded RNA.

'''NS5B''' is the '''RNA dependent RNA polymerase''' of Hepatitis C virus. NS5B, like other RNA dependent RNA polymerases, is error prone. This viral RNA replicase is of approximately a million times lower fidelity than a replicative prokayrotic or eukaryotic DNA polymerase. This is due in part to the fact that NS5B contains no exonuclease or proofreading domain. In NS5B, two divalent cations coordinated by carboxyl groups (as seen in DNA polymerases) catalyze the polymerization of monomers of RNA triphosphates to extend a primer strand, that may have initiated ''de novo''. In the case of NS5B the residues that coordinate divalent cations (Mg2+ or Mn2+ ''in vitro'') are the three <scene name='NS5B/Native_ns5b/7'>active site aspartates (220, 318 and 319)</scene> seen here (PDB entry [[2hai]]).

Though Hepatitis C virus is of the Flaviviridae family the structure of NS5B is similar to the polymerase of bacteriophage Φ 6. The similarity to the bacteriophage polymerase is due to NS5B containing a fully encircled active site. Like many template-dependent nucleotide polymerases, NS5B can be visualized similar to a right hand. NS5B contains several <scene name='NS5B/Native_ns5b/8'>domains</scene>, fingers in blue, palm in magenta, thumb in green and a c-terminal domain in yellow. Specific to Hepatitis C virus family, the NS5B protein has a 21-24 residue hydrophobic membrane anchor at its C-termini that allows involvement with the replication complex that is located in membrane bound vesicles derived from the endoplasmic reticulum. The fingers, palm, and thumb region of the NS5B contain 531 residues and are composed of 21 alpha helices and 18 beta barrels. The fingers region of NS5B can be divided into two distinct sections: the palm-proximal region and the distal region. The palm-proximal region is folded as a bundle of alpha helices and the distal region is composed of a singular beta barrel. These regions are termed the fingertips. The fingers domain interacts with the major groove of the template RNA and aids in recognition and binding. The fingers domain of NS5B are composed of a set of 4 beta strands that can establish contact with the thumb region closing the active site. The thumb region of HCV is structurally larger in comparison to other RdRps. It is composed mainly of alpha helices, 7 of them, and two beta hairpins. It contains amino acids 370-531. One is a <scene name='NS5B/Native_ns5b/9'>beta-hairpin in thumb domain</scene> that is proposed to move upon formation of exiting double-stranded RNA. The core of the thumb is composed of two repeating helix motifs. The thumb region of NS5B also contains a “priming loop” that extends from the thumb and provides stability during initiation. The palm domain contains the active site aspartates and there are several contacts between the fingers and thumbs domain that give the active site an encircled structure.

Line 15:

Line 18:

[http://www.nature.com/nrmicro/journal/v5/n6/fig_tab/nrmicro1645_F4.html This image] is a depiction of each of the protein products of NS5B genomic translation. The proteins coded for by the hepatitis C virus (HCV) genome all associate with the ER membrane. The proteins are translated as one large poly-protein that is enzymatically cleaved by both host and viral proteases. Of the several proteins that are coded for by HCV, three functions have been identified as relevant drug targets, these are the NS3 protease and helicase domains and the NS5B RNA dependent RNA polymerase. Currently the therapy for HCV is interferon therapy often in combination with ribavirin. This therapy however is inadequate; it is not effective in each genotype of HCV, it is not well tolerated, and is expensive. For these reasons many academic and industrial laboratories have been working on developing novel inhibitors of NS5B.

<scene name='NS5B/Cv/4'>Much of the x-ray crystallography work that has gone into NS5B to date</scene> (Ligands are from: 1C2P, 1CSJ, 1GX5, 1GX6, 1NB4, 1NB6, 1NB7, 1HNU, 1NHV, 1OS5, 1QUV, 1YUY, 1YV2, 1YVF, 1YVX, 1YVZ, 1Z4U, 2AWZ, 2AX0, 2AX1, 2BRK, 2BRL, 2D3U, 2D3Z, 2D41, 2GIQ, 2GIR, 2HWH, 2HWI, 2I1R, 2IJN, 2JC0, 2JC1, 3BR9, 3BSA, 3BSC, 3CIZ, 3CJ0, 3CJ2, 3CJ3, 3CJ4, 3CJ5). Superpositions in the scene by Rould MA, and Villanueva NL. Each of the forty three structures included in the superposition contain at least one ligand, the ligands range from ions and small molecules to nucleotides and non-nucleoside analogue inhibitors. Positioning the structure in the familiar orientation with the <scene name='NS5B/Ns5b_with_ligands/3'>domains</scene> colored as above, it is obvious that there are two primary areas where ligands are clustering. Several nucleotides, oligonucleotides and non-nucleoside analogue inhibitors can be found near the <scene name='NS5B/Ns5b_with_ligands/4'>active site</scene>. There is another site that is about 30-35Å from the active site, an <scene name='NS5B/Ns5b_with_ligands/5'>allosteric site</scene>, where again ligands are clustering. There is a rGTP binding site here that seems to activate the enzyme and a nearby site where inhibitors bind and disrupt the activity of the enzyme.

<scene name='NS5B/Cv/5'>Much of the x-ray crystallography work that has gone into NS5B to date</scene> (Ligands are from: 1C2P, 1CSJ, 1GX5, 1GX6, 1NB4, 1NB6, 1NB7, 1HNU, 1NHV, 1OS5, 1QUV, 1YUY, 1YV2, 1YVF, 1YVX, 1YVZ, 1Z4U, 2AWZ, 2AX0, 2AX1, 2BRK, 2BRL, 2D3U, 2D3Z, 2D41, 2GIQ, 2GIR, 2HWH, 2HWI, 2I1R, 2IJN, 2JC0, 2JC1, 3BR9, 3BSA, 3BSC, 3CIZ, 3CJ0, 3CJ2, 3CJ3, 3CJ4, 3CJ5). Superpositions in the scene by Rould MA, and Villanueva NL. Each of the forty three structures included in the superposition contain at least one ligand, the ligands range from ions and small molecules to nucleotides and non-nucleoside analogue inhibitors. Positioning the structure in the familiar orientation with the <scene name='NS5B/Ns5b_with_ligands/6'>domains</scene> colored as above, it is obvious that there are two primary areas where ligands are clustering. Several nucleotides, oligonucleotides and non-nucleoside analogue inhibitors can be found near the <scene name='NS5B/Ns5b_with_ligands/9'>active site</scene>. There is another site that is about 30-35Å from the active site, an <scene name='NS5B/Ns5b_with_ligands/8'>allosteric site</scene>, where again ligands are clustering. There is a rGTP binding site here that seems to activate the enzyme and a nearby site where inhibitors bind and disrupt the activity of the enzyme.

The inhibitors that bind near the <scene name='NS5B/Ns5b_with_ligands/4'>active site</scene> are thought to work by disrupting the ''primer grip'' site causing an inability of the enzyme to efficiently hold and extend a growing primer strand. The inhibitors that bind near the <scene name='NS5B/Ns5b_with_ligands/5'>allosteric site</scene> work through a poorly understood mechanism, several explanations for their ability to inhibit the enzyme have been proposed. The commonly proposed explanations are that these inhibitors lock the enzyme in an inactive conformation, inhibit binding of the rGTP that binds in the area and has been shown to stimulate activity, or that this interface is critical in protein-protein interactions and disruption of these interactions by the inhibitors disrupts an oligomerization of several NS5B protomers thus making each less efficient.

The inhibitors that bind near the <scene name='NS5B/Ns5b_with_ligands/9'>active site</scene> are thought to work by disrupting the ''primer grip'' site causing an inability of the enzyme to efficiently hold and extend a growing primer strand. The inhibitors that bind near the <scene name='NS5B/Ns5b_with_ligands/8'>allosteric site</scene> work through a poorly understood mechanism, several explanations for their ability to inhibit the enzyme have been proposed. The commonly proposed explanations are that these inhibitors lock the enzyme in an inactive conformation, inhibit binding of the rGTP that binds in the area and has been shown to stimulate activity, or that this interface is critical in protein-protein interactions and disruption of these interactions by the inhibitors disrupts an oligomerization of several NS5B protomers thus making each less efficient.

==3D structures of RNA polymerase==

Navigation menu

Page actions

Page actions

Personal tools

Navigation

Search

Tools

@@ Line 1: / Line 1: @@
-<StructureSection load='2HAI_catalytic3.pdb' size='450' side='right' scene='NS5B/Cv/3' caption=''>
+<StructureSection load='2HAI_catalytic3.pdb' size='350' side='right' scene='NS5B/Cv/3' caption='Hepatitis virus NS5B RNA polymerase complex with inhibitor (PDB code [[2hai]])'>
 ==RNA Dependent RNA Polymerase from Hepatitis C Virus==
-NS5B is the RNA dependent RNA polymerase of Hepatitis C virus. NS5B, like other RNA dependent RNA polymerases, is error prone. This viral RNA replicase is of approximately a million times lower fidelity than a replicative prokayrotic or eukaryotic DNA polymerase. This is due in part to the fact that NS5B contains no exonuclease or proofreading domain. IN NS5B two divalent cations coordinated by carboxyl groups (as seen in DNA polymerases) catalyze the polymerization of monomers of RNA triphosphates to extend a primer strand, that may have initiated ''de novo''. In the case of NS5B the residues that coordinate divalent cations (Mg2+ or Mn2+ ''in vitro'') are the three <scene name='NS5B/Native_ns5b/7'>active site aspartates (220, 318 and 319)</scene> seen here (PDB entry [[2hai]]).
-Though Hepatitis C virus is of the Flaviviridae family the structure of NS5B is similar to the polymerase of bacteriophage Φ 6. The similarity to the bacteriophage polymerase is due to NS5B containing a fully encircled active site. Like many template-dependent nucleotide polymerases, NS5B can be visualized similar to a right hand. NS5B contains several <scene name='NS5B/Native_ns5b/8'>domains</scene>, fingers in blue, palm in magenta, thumb in green and a c-terminal domain in yellow. The palm domain contains the active site aspartates and there are several contacts between the fingers and thumbs domain that give the active site an encircled structure. There is a
+In 2019, there were approximately 290,000 deaths due to a Hepatitis C infection. The majority of these deaths were largely due to the long-term adverse effects such as cirrhosis and liver cancer. Currently in the world, about 58 million people are chronically infected with the Hepatitis C virus and there are about 1.5 million new infections annually. In the United States, data estimates that 2.4 million people are infected with Hepatitis C. Due to the low percentage of diagnoses and the frequency of acute infection, it is believed that the number of Hepatitis C infections can range anywhere from 2.5 million to 4.7 million infected individuals. Nearly all of RNA viruses depend on specific activities performed by RNA dependent RNA polymerases (RdRp). These activities importantly include the copying of the RNA sequence and facilitating the process of transcription. Therefore, if a vaccine was created to target the RNA dependent RNA polymerase and inhibit the function of this protein, then the viral genome could not be replicated. If replication halts, the infection cannot spread to other cells. Due to the viral dependence on RdRps, it is essential to understand the structure for further antiviral drug research.  [[Sofosbuvir]] is an inhibitor of NS5B used for Hepatitis C treatment.
-<scene name='NS5B/Native_ns5b/9'>beta-hairpin in thumb domain</scene> that is proposed to move upon formation of exiting double stranded RNA.
+'''NS5B''' is the '''RNA dependent RNA polymerase''' of Hepatitis C virus. NS5B, like other RNA dependent RNA polymerases, is error prone. This viral RNA replicase is of approximately a million times lower fidelity than a replicative prokayrotic or eukaryotic DNA polymerase. This is due in part to the fact that NS5B contains no exonuclease or proofreading domain. In NS5B, two divalent cations coordinated by carboxyl groups (as seen in DNA polymerases) catalyze the polymerization of monomers of RNA triphosphates to extend a primer strand, that may have initiated ''de novo''. In the case of NS5B the residues that coordinate divalent cations (Mg2+ or Mn2+ ''in vitro'') are the three <scene name='NS5B/Native_ns5b/7'>active site aspartates (220, 318 and 319)</scene> seen here (PDB entry [[2hai]]).
+Though Hepatitis C virus is of the Flaviviridae family the structure of NS5B is similar to the polymerase of bacteriophage Φ 6. The similarity to the bacteriophage polymerase is due to NS5B containing a fully encircled active site. Like many template-dependent nucleotide polymerases, NS5B can be visualized similar to a right hand. NS5B contains several <scene name='NS5B/Native_ns5b/8'>domains</scene>, fingers in blue, palm in magenta, thumb in green and a c-terminal domain in yellow. Specific to Hepatitis C virus family, the NS5B protein has a 21-24 residue hydrophobic membrane anchor at its C-termini that allows involvement with the replication complex that is located in membrane bound vesicles derived from the endoplasmic reticulum. The fingers, palm, and thumb region of the NS5B contain 531 residues and are composed of 21 alpha helices and 18 beta barrels. The fingers region of NS5B can be divided into two distinct sections: the palm-proximal region and the distal region. The palm-proximal region is folded as a bundle of alpha helices and the distal region is composed of a singular beta barrel. These regions are termed the fingertips. The fingers domain interacts with the major groove of the template RNA and aids in recognition and binding. The fingers domain of NS5B are composed of a set of 4 beta strands that can establish contact with the thumb region closing the active site.  The thumb region of HCV is structurally larger in comparison to other RdRps. It is composed mainly of alpha helices, 7 of them, and two beta hairpins. It contains amino acids 370-531. One is a <scene name='NS5B/Native_ns5b/9'>beta-hairpin in thumb domain</scene> that is proposed to move upon formation of exiting double-stranded RNA. The core of the thumb is composed of two repeating helix motifs. The thumb region of NS5B also contains a “priming loop” that extends from the thumb and provides stability during initiation. The palm domain contains the active site aspartates and there are several contacts between the fingers and thumbs domain that give the active site an encircled structure.
@@ Line 15: / Line 18: @@
 [http://www.nature.com/nrmicro/journal/v5/n6/fig_tab/nrmicro1645_F4.html This image] is a depiction of each of the protein products of NS5B genomic translation. The proteins coded for by the hepatitis C virus (HCV) genome all associate with the ER membrane. The proteins are translated as one large poly-protein that is enzymatically cleaved by both host and viral proteases. Of the several proteins that are coded for by HCV, three functions have been identified as relevant drug targets, these are the NS3 protease and helicase domains and the NS5B RNA dependent RNA polymerase. Currently the therapy for HCV is interferon therapy often in combination with ribavirin. This therapy however is inadequate; it is not effective in each genotype of HCV, it is not well tolerated, and is expensive. For these reasons many academic and industrial laboratories have been working on developing novel inhibitors of NS5B.
-<scene name='NS5B/Cv/4'>Much of the x-ray crystallography work that has gone into NS5B to date</scene> (Ligands are from: 1C2P, 1CSJ, 1GX5, 1GX6, 1NB4, 1NB6, 1NB7, 1HNU, 1NHV, 1OS5, 1QUV, 1YUY, 1YV2, 1YVF, 1YVX, 1YVZ, 1Z4U, 2AWZ, 2AX0, 2AX1, 2BRK, 2BRL, 2D3U, 2D3Z, 2D41, 2GIQ, 2GIR, 2HWH, 2HWI, 2I1R, 2IJN, 2JC0, 2JC1, 3BR9, 3BSA, 3BSC, 3CIZ, 3CJ0, 3CJ2, 3CJ3, 3CJ4, 3CJ5). Superpositions in the scene by Rould MA, and  Villanueva NL. Each of the forty three structures included in the superposition contain at least one ligand, the ligands range from ions and small molecules to nucleotides and non-nucleoside analogue inhibitors. Positioning the structure in the familiar orientation with the <scene name='NS5B/Ns5b_with_ligands/3'>domains</scene> colored as above, it is obvious that there are two primary areas where ligands are clustering. Several nucleotides, oligonucleotides and non-nucleoside analogue inhibitors can be found near the <scene name='NS5B/Ns5b_with_ligands/4'>active site</scene>. There is another site that is about 30-35Å from the active site, an <scene name='NS5B/Ns5b_with_ligands/5'>allosteric site</scene>, where again ligands are clustering. There is a rGTP binding site here that seems to activate the enzyme and a nearby site where inhibitors bind and disrupt the activity of the enzyme.
+<scene name='NS5B/Cv/5'>Much of the x-ray crystallography work that has gone into NS5B to date</scene> (Ligands are from: 1C2P, 1CSJ, 1GX5, 1GX6, 1NB4, 1NB6, 1NB7, 1HNU, 1NHV, 1OS5, 1QUV, 1YUY, 1YV2, 1YVF, 1YVX, 1YVZ, 1Z4U, 2AWZ, 2AX0, 2AX1, 2BRK, 2BRL, 2D3U, 2D3Z, 2D41, 2GIQ, 2GIR, 2HWH, 2HWI, 2I1R, 2IJN, 2JC0, 2JC1, 3BR9, 3BSA, 3BSC, 3CIZ, 3CJ0, 3CJ2, 3CJ3, 3CJ4, 3CJ5). Superpositions in the scene by Rould MA, and  Villanueva NL. Each of the forty three structures included in the superposition contain at least one ligand, the ligands range from ions and small molecules to nucleotides and non-nucleoside analogue inhibitors. Positioning the structure in the familiar orientation with the <scene name='NS5B/Ns5b_with_ligands/6'>domains</scene> colored as above, it is obvious that there are two primary areas where ligands are clustering. Several nucleotides, oligonucleotides and non-nucleoside analogue inhibitors can be found near the <scene name='NS5B/Ns5b_with_ligands/9'>active site</scene>. There is another site that is about 30-35Å from the active site, an <scene name='NS5B/Ns5b_with_ligands/8'>allosteric site</scene>, where again ligands are clustering. There is a rGTP binding site here that seems to activate the enzyme and a nearby site where inhibitors bind and disrupt the activity of the enzyme.
-The inhibitors that bind near the <scene name='NS5B/Ns5b_with_ligands/4'>active site</scene> are thought to work by disrupting the ''primer grip'' site causing an inability of the enzyme to efficiently hold and extend a growing primer strand. The inhibitors that bind near the <scene name='NS5B/Ns5b_with_ligands/5'>allosteric site</scene> work through a poorly understood mechanism, several explanations for their ability to inhibit the enzyme have been proposed. The commonly proposed explanations are that these inhibitors lock the enzyme in an inactive conformation, inhibit binding of the rGTP that binds in the area and has been shown to stimulate activity, or that this interface is critical in protein-protein interactions and disruption of these interactions by the inhibitors disrupts an oligomerization of several NS5B protomers thus making each less efficient.
+The inhibitors that bind near the <scene name='NS5B/Ns5b_with_ligands/9'>active site</scene> are thought to work by disrupting the ''primer grip'' site causing an inability of the enzyme to efficiently hold and extend a growing primer strand. The inhibitors that bind near the <scene name='NS5B/Ns5b_with_ligands/8'>allosteric site</scene> work through a poorly understood mechanism, several explanations for their ability to inhibit the enzyme have been proposed. The commonly proposed explanations are that these inhibitors lock the enzyme in an inactive conformation, inhibit binding of the rGTP that binds in the area and has been shown to stimulate activity, or that this interface is critical in protein-protein interactions and disruption of these interactions by the inhibitors disrupts an oligomerization of several NS5B protomers thus making each less efficient.
 ==3D structures of RNA polymerase==